May 2019


In this Issue

Critical Limb Ischemia

Clinical trial updates, technical tips, and collaborative approaches to care.



Guest Chief Medical Editors’ Page

Surveying the CLI Landscape

By Jos C. van den Berg, MD, PhD, and Jihad A. Mustapha, MD


CLI Trial Update: Where Do We Stand on Data Collection?

An overview of the current evidence and perspectives on what data are still needed.

By Bram Fioole, MD, PhD; Joost A. Bekken, MD; and Hence Verhagen, MD, PhD

CLI Trial Update: The CRITISCH Registry

Investigators provide an overview of registry data examining various treatment options for patients with CLI.

By Theodosios Bisdas, MD; Giovanni Torsello, MD; and Konstantinos Stavroulakis, MD

CLI Trial Update: The BEST-CLI Trial

A summary of the trial’s design and goals and an update on its progress to date.

By Matthew Menard, MD; Alik Farber, MD; and Kenneth Rosenfield, MD

CLI Management and Outpatient Center Considerations

Factors to consider in providing specialized care for this patient population.

By Fadi Saab, MD; Bret N. Wiechmann, MD; and Christopher LeSar, MD

Ask the Experts: What Is Your Top Tip on How to Safely and Efficiently Cross a Lower Extremity CTO?

Experts discuss their access approaches to and techniques for crossing chronic total occlusions.

With John A. Phillips, MD; Saher Sabri, MD, FSIR; Ramon L. Varcoe, MBBS, MS, FRACS, PhD; Sabine Steiner, MD; and Osamu Iida, MD

Optimal Medical Therapy for CLI: Recent Advances and the Need for More Data

A conversation with the President of the Society for Vascular Medicine on current best practices for medical therapy in this challenging population.

With Heather L. Gornik, MD

CLI Revascularization Advice From a Surgeon Who Performs Distal Bypass

Decisions regarding type of therapy and insights from a surgeon to endovascular specialists.

By Richard F. Neville, MD, FACS

Ask the Experts: What Are Your Surveillance Protocols After Below-the-Knee Interventions, and What Determines the Need for Reintervention?

Experts discuss their approach to postprocedural management.

With John H. Rundback, MD; Marianne Brodmann, MD; Misaki Kiguchi, MD, MBA, MSc, RPVI; and Thomas Zeller, MD, PhD

Critical Limb Ischemia: A Threat to Life and Limb

CLI is an underdiagnosed and undertreated deadly disease that requires proper diagnostic imaging and increased awareness.

By Jihad A. Mustapha, MD; Barry T. Katzen, MD; Richard F. Neville, MD, FACS; Robert A. Lookstein, MD; Thomas Zeller, MD, PhD; Larry E. Miller, PhD; Vickie R. Driver, DPM; and Michael R. Jaff, DO


FDA Paclitaxel Safety Panel Preview

An interview with FDA CDRH representatives discussing the upcoming advisory panel meeting to review concerns and current data on paclitaxel-eluting device use.

By Kenneth Cavanaugh, PhD; and Misti Malone, PhD


Mentors and Protégés: Conversations on Career and Craft With Riad Salem, MD

Alexander Logsdon, DO, and Adam Sucher, DO, talk with Dr. Salem about balancing research and clinical responsibilities, his journey in establishing Y-90 as a standard of care, and his advice to aspiring clinical researchers, among other topics.


Sponsored by Silk Road Medical

The Shifting Paradigm in Carotid Revascularization: TCAR in Real-World Practice

By Marc Schermerhorn, MD; and Patric Liang, MD; with an accompaniment by Bernardino C. Branco Rocha, MD


Sponsored by Medtronic

Peripheral Artery Disease Below the Knee: Unique Challenges and Algorithmic Solutions

By Peter P. Monteleone, MD



An Interview With Tilo Kölbel, MD, PhD

Dr. Kölbel shares his protocols for false lumen occlusion in TEVAR, updates on stroke and spinal cord ischemia prevention, and more.


Contact Info

For advertising rates and opportunities, contact:
Craig McChesney

Stephen Hoerst

Charles Philip

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.